Patel, Dilan A.
Crain, Mallory
Pusic, Iskra
Schroeder, Mark A. https://orcid.org/0000-0003-4924-8990
Article History
Accepted: 5 May 2023
First Online: 29 May 2023
Declarations
:
: DP wrote the manuscript and the table. MC edited the table. MC, IP, and MS provided a conceptual overview for the topics discussed and provided edits on both the manuscript and table.
: DP does not have any conflicts of interest. MC does not have any conflicts. IP has the following conflicts (Advisory board for Syndax Pharmaceuticals and Incyte). MS has the following conflicts (Advisory boards and received honorary or consulting fees: Equillium Inc, GSK, and Incyte).
: Not applicable.
: Not applicable.
: Not applicable.
: No datasets were generated or analyzed during the current study.
: Not applicable.